Integrin ligands

US7279468B2 · kind B2 · utility

Assignee

• Abbott GmbH & Co. KG · DE

Inventors

• Hervé Geneste · Schifferstadt, DE
• Andreas Kling · Mannheim, DE
• Udo Lange · Ludwigshafen, DE
• Werner Seitz · Plankstadt, DE
• Claudia Isabella Graef · Mannheim, DE
• Thomas Subkoski · Ladenburg, DE
• Wilfried Hornberger · Wiesbaden, DE
• Arnulf Lauterbach · Ludwigshafen, DE

Key dates

• Filing date: Jun 15, 2001
• Grant date: Oct 9, 2007
• Expiry date: Apr 12, 2022

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P9/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to novel compounds which bind to integrin receptors, their use as ligands of integrin receptors, in particular as ligands of the αvβ3 integrin receptor, their use, and pharmaceutical preparations comprising these compounds.